Soleno Therapeutics (SLNO) CEO pay: $63.2M actually paid in FY2024
$SLNO · SOLENO THERAPEUTICS INCData through FY2024 — latest proxy filed 2025-04-22, checked for new filings 2026-08-21. Every number links to its source.
16.1× the tracked-company median CEO pay ($3.9M).
Pay vs. Performance (Compensation Actually Paid)
What the CEO was actually paid, by fiscal year
What $100 invested was worth, company vs peer group
Pay-vs-Performance table
| FY | CEO pay on paper | CEO pay actually earned | Other top execs (avg) | Value of $100 invested since FY2021 | Same, peer group since FY2021 | Net income |
|---|---|---|---|---|---|---|
| 2024 | $51.2M | $63.2M | $9.0M | $679.10 | — | -$175.5M |
| 2023 | $4.1M | $29.0M | $5.7M | $608.08 | — | -$39.0M |
| 2022 | $1.1M | $707,389 | $476,813 | $29.91 | — | -$24.1M |
| 2021 | $4.4M | $313,041 | $190,396 | $20.40 | — | -$30.9M |
Frequently asked
How much did the SLNO CEO make in 2024?
$63,219,718 in Compensation Actually Paid (CAP) as SOLENO THERAPEUTICS INC's CEO (the filing reports this year's PEO pay without tagging which named executive it belongs to), updated 2025-04-22.
What is pay vs. performance (PvP)?
An SEC disclosure (Item 402(v), required since FY2022) linking named-executive pay to company total shareholder return (TSR) over up to 5 years.
What is Compensation Actually Paid (CAP)?
CAP starts from the Summary Compensation Table total and adjusts equity awards to fair value as of each year-end/vesting date, rather than grant-date value — see the glossary entry for the full walk-through.
Also on SLNO: SEC & DOJ enforcement actions · CEO track-record ranking · Glossary